3rd Molecular Glue Drug Development Summit The Royal Sonesta Boston, Boston
Molecular glue development continues to thrive, offering exciting opportunities to target previously undruggable proteins and treat a wide range of diseases. 2024 has seen a multitude of collaborations, with Takeda and Degron Therapeutics entering a deal worth $1.2 billion.
The 3rd Molecular Glue Drug Development Summit returns as the only industry-dedicated forum bringing together 90+ experts as they showcase the latest advancements and breakthroughs in molecular glue drug development through discussions and data-driven case studies on screening tools, novel mechanisms of actions of proximity-based degrading and non-degrading molecular glues and lead optimization strategies, to streamline discovery and development of safe and effective glues.
Go to Event Website
Drug Developer Pricing - Full Access Pass (Conference + 2 Workshops): USD 4197.00, Drug Developer Pricing - 3 Day Pass (Conference + 1 Workshop): USD 3598.00, Drug Developer Pricing - 2 Day Pass (Conference Only): USD 2999.00, Academic Pricing - Full Access Pass (Conference + 2 Workshops): USD 3597.00, Academic Pricing - 3 Day Pass (Conference + 1 Workshop): USD 3098.00, Academic Pricing - 2 Day Pass (Conference Only): USD 2599.00, Service and Solution Provider Pricing - Full Access Pass (Conference + 2 Workshops): USD 5097.00, Service and Solution Provider Pricing - 3 Day Pass (Conference + 1 Workshop): USD 4398.00, Service and Solution Provider Pricing - 2 Day Pass (Conference Only): USD 3699.00
Advertisements